A peptide of the N terminus of GRK5 attenuates pressure-overload hypertrophy and heart failure-Reference-Cited by-同舟云学术

A peptide of the N terminus of GRK5 attenuates pressure-overload hypertrophy and heart failure

Published:2021-03-30 Issue:676 Volume:14 Page:
ISSN:1945-0877
Container-title:Science Signaling
language:en
Short-container-title:Sci. Signal.

Author:

Coleman Ryan C.¹^ORCID,Eguchi Akito¹^ORCID,Lieu Melissa¹,Roy Rajika¹^ORCID,Barr Eric W.¹,Ibetti Jessica¹^ORCID,Lucchese Anna-Maria¹^ORCID,Peluzzo Amanda M.¹^ORCID,Gresham Kenneth¹,Chuprun J. Kurt¹^ORCID,Koch Walter J.¹^ORCID

Affiliation:

1. Center for Translational Medicine, Lewis Katz School of Medicine at Temple University, Philadelphia, PA 19140, USA.

Abstract

GRK5 does not mediate pathological signaling in the heart if its nuclear translocation is disrupted.

Funder

National Institutes of Health

NIH Clinical Center

American Heart Association

Animal Health Australia

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference48 articles.

1. Seven-transmembrane-spanning receptors and heart function

2. Emerging paradigms of β-arrestin-dependent seven transmembrane receptor signaling

3. Structural Studies of G Protein-Coupled Receptors

4. G protein-coupled receptor kinases in normal and failing myocardium

5. The Evolving Impact of G Protein-Coupled Receptor Kinases in Cardiac Health and Disease

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioactive Compounds and Cardiac Fibrosis: Current Insight and Future Prospect;Journal of Cardiovascular Development and Disease;2023-07-21

2. Novel roles for G protein-coupled receptor kinases in cardiac injury and repair;Biochemical Society Transactions;2023-04-04

3. Emerging Therapeutic Targets for Heart Failure;Current Cardiology Reports;2022-10-04

4. Estrogen signaling as a bridge between the nucleus and mitochondria in cardiovascular diseases;Frontiers in Cell and Developmental Biology;2022-09-14

5. Empagliflozin attenuates cardiac microvascular ischemia/reperfusion through activating the AMPKα1/ULK1/FUNDC1/mitophagy pathway;Redox Biology;2022-06